{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:17:55Z","timestamp":1791505075606,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jsbmb.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T18:48:57Z","timestamp":1440182937000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human"],"prefix":"10.1016","volume":"154","author":[{"given":"Matthew A.","family":"Cerny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Csengery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schmenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosea","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2015.08.004_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mce.2011.07.019","article-title":"Non-genomic actions of aldosterone: from receptors and signals to membrane targets","volume":"350","author":"Dooley","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1440-1681.2010.05352.x","article-title":"Expanding view of aldosterone action, with an emphasis on rapid action","volume":"37","author":"Vinson","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0015","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/ndt\/gfg265","article-title":"Non-genomic actions of aldosterone: mechanisms and consequences in kidney cells","volume":"18","author":"Boldyreff","year":"2003","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00041552-200103000-00011","article-title":"Non-genomic actions of aldosterone: role in hypertension","volume":"10","author":"Funder","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0025","doi-asserted-by":"crossref","unstructured":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]), Am J Cardiol., 78 (1996) 902\u2013907.","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI heart failure efficacy and survival study","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0035","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenonea selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrneph.2009.228","article-title":"Aldosterone \u2018escape\u2019 vs \u2018breakthrough\u2019","volume":"6","author":"Schrier","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0050","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1097\/01.ASN.0000086472.65806.73","article-title":"Aldosterone in chronic kidney and cardiac disease","volume":"14","author":"Hostetter","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041552-200303000-00006","article-title":"Aldosterone in renal disease","volume":"12","author":"Ibrahim","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ki.2011.48","article-title":"Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease","volume":"79","author":"Bertocchio","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0065","doi-asserted-by":"crossref","first-page":"B46","DOI":"10.1093\/eurheartj\/sur005","article-title":"Aldosterone blockade: current research and future trends","volume":"13","author":"Bramlage","year":"2011","journal-title":"Eur. Heart J. Supp."},{"issue":"1038","key":"10.1016\/j.jsbmb.2015.08.004_bib0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrd3431","article-title":"Novel therapeutic targets for the treatment of heart failure","volume":"10","author":"Tamargo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0075","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1021\/bi000079k","article-title":"Crystal structures of adrenodoxin reductase in complex with NADP+ and NADPH suggesting a mechanism for the electron transfer of an enzyme family","volume":"39","author":"Ziegler","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbapap.2010.06.003","article-title":"Adrenodoxin: the archetype of vertebrate-type [2Fe-2S] cluster ferredoxins","volume":"1814","author":"Ewen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0085","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0090","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2174\/1568026611313120003","article-title":"Progress towards clinically useful aldosterone synthase inhibitors","volume":"13","author":"Cerny","year":"2013","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ndt\/gfs388","article-title":"Aldosterone synthase inhibition in humans","volume":"28","author":"Azizi","year":"2013","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ab.2014.06.011","article-title":"Development of a high-throughput assay for aldosterone synthase inhibitors using high-performance liquid chromatography-tandem mass spectrometry","volume":"462","author":"Yurek","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.mce.2003.10.027","article-title":"Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension","volume":"217","author":"Bureik","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/07435809509030460","article-title":"Cloning of CYP11B1 and CYP11B2 from normal human adrenal and their functional expression in COS-7 and V79Chinese hamster cells","volume":"21","author":"Denner","year":"1995","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00008571-199504000-00005","article-title":"Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79Chinese hamster cells and their application for testing of potential inhibitors","volume":"5","author":"Denner","year":"1995","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0960-0760(02)00056-0","article-title":"Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells","volume":"81","author":"Ehmer","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ab.2009.07.025","article-title":"Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors","volume":"394","author":"LaSala","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0130","unstructured":"H.-L.R.I. Johannes Aebi, Kurt Amrein, Benoit Hornsperger, Wenming Chen, Benoit Hornsperger, Bernd Kuhn, Yongfu Liu, Hans P. Maerki, Alexander V. Mayweg, Peter Mohr, Xuefei Tan, Zhanguo Wang, Mingwei Zhou, New Bicyclic Dihydroisoquinoline-1-one derivatives, in: H.-L.R. Inc. (Ed.), Hoffmann-La Roche Inc., United States, 2013, pp. 1\u2013169."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1124\/jpet.110.167148","article-title":"Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone","volume":"334","author":"Rigel","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12967-014-0340-9","article-title":"Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects","volume":"12","author":"Menard","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0145","article-title":"The CYP 11B subfamily","author":"Schiffer","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0150","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1021\/jm800888q","article-title":"In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives","volume":"51","author":"Lucas","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0155","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1021\/acs.jmedchem.5b00407","article-title":"Structure-activity relationships, pharmacokinetics, and in vivo activity of CYP11B2 and CYP11B1 inhibitors","volume":"58","author":"Papillon","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0160","article-title":"Preparation of pyridinylindole derivatives for use as aldosterone synthase modulators","author":"Adams","year":"2009","journal-title":"Novartis AG"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mce.2011.08.041","article-title":"Human adrenocortical carcinoma cell lines","volume":"351","author":"Wang","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0175","doi-asserted-by":"crossref","first-page":"E1351","DOI":"10.1152\/ajpendo.00653.2005","article-title":"Regulation of steroid hormone biosynthesis enzymes and organic anion transporters by forskolin and DHEA-S treatment in adrenocortical cells","volume":"291","author":"Asif","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00424-004-1373-3","article-title":"Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells","volume":"450","author":"Asif","year":"2005","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0185","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.2000.278.6.C1256","article-title":"Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells","volume":"278","author":"Bello-Reuss","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0190","first-page":"5488","article-title":"Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis","volume":"50","author":"Gazdar","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/dmd.32.6.647","article-title":"Validated assays for human cytochrome P450 activities","volume":"32","author":"Walsky","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.abb.2010.08.017","article-title":"Multi-step oxidations catalyzed by cytochrome P450 enzymes: processive vs. distributive kinetics and the issue of carbonyl oxidation in chemical mechanisms","volume":"507","author":"Guengerich","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-62703-758-7_6","article-title":"Multienzyme kinetics and sequential metabolism","volume":"1113","author":"Wienkers","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0210","first-page":"4326","article-title":"Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase","volume":"86","author":"Fisher","year":"2001","journal-title":"J. Clin..Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/me.2012-1287","article-title":"Structural insights into aldosterone synthase substrate specificity and targeted inhibition","volume":"27","author":"Strushkevich","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2012.03.002","article-title":"Human aldosterone synthase: recombinant expression in E. coli and purification enables a detailed biochemical analysis of the protein on the molecular level","volume":"132","author":"Hobler","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/eje.0.1470795","article-title":"Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas","volume":"147","author":"Fallo","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0230","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-4658.2008.06253.x","article-title":"Purification and functional characterization of human 11beta hydroxylase expressed in E. coli","volume":"275","author":"Zollner","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0235","first-page":"1","article-title":"Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes","volume":"26","author":"Chauret","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jsbmb.2015.08.004_bib0240","first-page":"141","article-title":"Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes","volume":"29","author":"Easterbrook","year":"2001","journal-title":"Drug Metab. Dispos."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076015300418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076015300418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:49:36Z","timestamp":1760744976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076015300418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":48,"alternative-id":["S0960076015300418"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2015.08.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}